In recent studies targeting Crohn’s disease in humans, it was evidenced that the kinase MAP3K4 (Mitogen-activated protein kinase 4) was responsible for variation of IL1A, regardless of variation in TLR activation [30]. This evidence concerns the gene MAP2K4 and Crohn disease.